Filters

anti-Chemokine receptor-like 1 (N-term, Extracell. Dom.) Antibody

anti-Chemokine receptor-like 1 (N-term, Extracell. Dom.) Antibody size: 50 Ð’µg 732

Supplier ACR
Price 732
Size 50 Ð’µg
Vial description CHEMR23, DEZ, CMKLR1
Categoryprimary antibody
Raised inRabbit
Clone1 vial
FormAffinity Purified
ReactivityHumanrimate
Puritypurified
Molecular weightin kDa
Sourcemammalian
Activityto be determined
Rangebroad
Protein numberQ99788
ApplicationImmunocytochemistry/Immunofluorescence
Storage Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4°
Description 2 or 3 and , Chemokines, Freeze thaw will destroy a percentage in every cycle and should be avoided, However, In this sense, The receptors are ligand binding factors of type 1, When such chemical-signals couple or bind to a receptor, a change in the electrical-activity of a cell, acetylcholine, am olfactory receptor is a protein-molecule that recognizes and responds to , an acetylcholine-receptor recognizes and responds to its endogenous-ligand, chemokine receptors, chemokinesor cytokines e, e, ligands , motif chemokines and cytokines are supplied by acr in 1, sometimes in pharmacology, such as enzymes, the term is also used to include other proteins that are drug-targets, they cause some form of cellular/tissue-response, transporters and ion-channels, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4°, endogenous-chemical signals, g, g, protein-molecules , that receive chemical-signals from outside a cell
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24°
Gene target Dom, Extracell, Chemokine receptor-like 1 (N-term
Short name Dom, Extracell, ) Antibody, anti-Chemokine receptor-like 1 (N-term
Technique antibodies against human proteins, antibodies for, antibody to, Antibody
Alternative name Dom, Extracell, ) (Antibody to), antibody to-Chemokine receptor-like 1 (n terminus
Alternative techniqueantibodies

Subscribe to our Newsletter